Man Group
ALBO

Man Group’s Albireo Pharma Inc ALBO Stock Holding History

Man Group’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-22,889
Closed -$533K – 2438
2021
Q4 		$533K Sell
22,889
-868
-4% -$23.1K ﹤0.01% 1513
2021
Q3 		$741K Buy
23,757
+1,673
+8% +$51.8K ﹤0.01% 1440
2021
Q2 		$777K Sell
22,084
-4,979
-18% -$162K ﹤0.01% 1444
2021
Q1 		$954K Buy
27,063
+35
+0.1% +$1.29K ﹤0.01% 1304
2020
Q4 		$1.01M Buy
27,028
+8,725
+48% +$317K ﹤0.01% 1413
2020
Q3 		$611K Buy
18,303
+865
+5% +$25.2K ﹤0.01% 1501
2020
Q2 		$462K Buy
+17,438
New +$411K ﹤0.01% 1466
2020
Q1 		– Sell
-94,187
Closed -$2.39M – 1968
2019
Q4 		$2.39M Sell
94,187
-98,663
-51% -$1.97M 0.01% 1283
2019
Q3 		$3.86M Buy
192,850
+3,350
+2% +$86.7K 0.01% 987
2019
Q2 		$6.11M Buy
189,500
+167,729
+770% +$5.61M 0.02% 861
2019
Q1 		$701K Buy
+21,771
New +$586K ﹤0.01% 1662

Other funds holding ALBO

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
DCMIC
Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Man Group's ALBO Position: Q1 2022 in Review

Man Group sold out of Albireo Pharma Inc (ALBO) in Q1 2022, closing a stake of 22,889 shares — an estimated $533K sold.

Man Group first reported a position in ALBO in Q1 2019 and held it in 11 quarters. The position peaked at $6.11M in Q2 2019. 109 funds tracked by Wall St. Rank hold ALBO as of Q1 2022.

  • Man Group reported no remaining Albireo Pharma Inc position as of Q1 2022 after selling out during the quarter.
  • Man Group sold 22,889 Albireo Pharma Inc shares in Q1 2022, an estimated $533K.
  • Man Group first reported a position in Albireo Pharma Inc in Q1 2019 and held it in 11 quarters.
  • Man Group's Albireo Pharma Inc position peaked at $6.11M in Q2 2019.
  • 109 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2022.

Based on Man Group's 13F filing for Q1 2022, filed 16 May 2022.